Remove 2015 Remove Research Remove Small Molecule Remove Targeted Protein Degradation
article thumbnail

New trends in DNA-encoded library screening

Drug Discovery World

In the 13 years since it was first described, DNA-encoded library (DEL) technology has become a firmly established approach to small molecule hit generation in drug discovery. Targeted protein degradation and related modalities. Screening of DNA-Encoded Small Molecule Libraries inside a Living Cell.

DNA 130
article thumbnail

Antibody-drug conjugates payloads: then, now and next

Drug Target Review

The research community pressed on, turning to novel compounds that were substantially more potent than those used in the first generation. Groundbreaking strategies like proteolysis-targeting chimeric molecules (PROTACs) are also being explored. Dual cytotoxic payload ADCs could address the inherent heterogeneity in tumours.

article thumbnail

Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket

The Pharma Data

We are happy to support their scientific efforts as they tackle complex research challenges that potentially address critical unmet medical needs for patients. Our Degradomer® class of targeted protein degraders expands on the Trilomer® concept, allowing highly specific degradation of disease-causing proteins.